Within3 Reimagines Life Science Communications to Address Insight Gaps with Industry-first, Holistic Platform

Within3 Select, Connect, and Discover follow strategic path creating the Insights Management Platform Within3’s hybrid engagement platform is proven to increase the volume, quality, and value of insights generated by life science innovators, their key opinion leaders, patients, and other stakeholders. That’s why multidisciplinary teams in the largest pharmaceutical and medical device companies use Within3 […]

thaipr.net

17 ก.ย. 64

PharmaZell and Novasep enter into exclusive negotiations in new drive to create a technology-driven leader for complex small molecules and ADCs of global scale

PharmaZell, the German producer of highly resilient and specialty APIs, and France-based Novasep, a leading CDMO focused on complex small molecules and ADCs have entered into exclusive negotiations to create a leading European platform in the attractive API manufacturing and CDMO space with a complementary set of differentiated technologies and highly diversified base of blue-chip […]

thaipr.net

17 ก.ย. 64

Satisfai Health acquires global license for AI software to detect early cancer in Barrett’s Esophagus

Advanced real-time clinical diagnostics for up to 150 million people Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy, has acquired an exclusive global license from the University of Augsburg and the OTH Regensburg, Technical University of Applied Sciences, in Germany. Satisfai will further develop AI software […]

thaipr.net

17 ก.ย. 64

RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval

The South African Health Products Regulatory Authority (SAHPRA) has approved the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care Number of U.S. sites for the study has also been expanded RHB-107, a novel antiviral serine protease inhibitor targeting human cell factors, is expected to […]

thaipr.net

15 ก.ย. 64

ABILITY Diabetes Global enrolls thousandth patient: A Cardinal Milestone Achieved

ABILITY Diabetes Global (Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents versus Everolimus-Eluting Stents in Coronary Artery Disease Patients with Diabetes Mellitus Global) started off with the index patient enrolment on 11th June 2020 in Italy (at the peak of the 1st wave of COVID-19 pandemic) by P.I. Prof. Antonio Colombo and the pace of enrolment since then has been steady and consistent, with […]

thaipr.net

10 ก.ย. 64

New Global Study Supports Healthy Buildings as a Critical Public Health Strategy

Study substantiates prior findings that improved indoor air quality leads to enhanced cognitive function and health of building occupants  For the first time on a global scale, new research has found that healthy buildings with enhanced ventilation can improve the cognitive function and health of occupants, suggesting that ventilation and filtration are preeminent healthy building […]

thaipr.net

10 ก.ย. 64

DiaCarta Receives CE/IVD for its New COVID 19 Screening Test that Identifies Delta Plus and New Variants

DiaCarta Inc., a precision molecular diagnostics company and leading developer of novel oncology tests using liquid biopsy today announced that its new QuantiVirus™ SARS-CoV-2 Variant Detection Test received the CE/IVD marking and therefore, can now be commercialized within the EU and the rest of the world. This new multiplex qPCR-based test screens for the SARS-CoV-2 […]

thaipr.net

10 ก.ย. 64

RedHill Biopharma’s Opaganib Demonstrates Significant Decrease of Kidney Fibrosis

– COVID-19 and long COVID patients are at increased risk of developing kidney damage – Opaganib significantly decreased kidney fibrosis in a preclinical in vivo model – Renal fibrosis is a progressive process which occurs in patients with chronic kidney disease (CKD) and can ultimately lead to end-stage renal failure – Opaganib is a novel, late clinical-stage oral pill […]

thaipr.net

10 ก.ย. 64

Gan & Lee Pharmaceuticals to present recent data at the 57th Annual European Association for the Study of Diabetes Meeting

Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee, stock code: 603087.SH), is excited to present positive data from five recent abstracts which will be featured as short oral discussions at the 57th Annual European Association for the Study of Diabetes (EASD) Meeting. The meeting will be held virtually from September 27th – […]

thaipr.net

9 ก.ย. 64

Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza

— First participants enrolled in Phase 1 clinical trial of combination NanoFlu™/NVX–CoV2373 vaccine with Matrix-M™ adjuvant — Phase 1/2 study will evaluate immunogenicity and safety Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced enrollment of the first participants in a Phase 1/2 study to evaluate […]

thaipr.net

9 ก.ย. 64
1 51 52 53 54 55 73